SIM
CC icon

Stelliam Investment Management’s Chemours CC Stock Holding History

Stelliam Investment Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-297,500
Closed -$14.5M – 45
2018
Q1 		$14.5M Buy
+297,500
New +$14.9M 0.61% 43

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stelliam Investment Management's CC Position: Q2 2018 in Review

Stelliam Investment Management sold out of Chemours (CC) in Q2 2018, closing a stake of 297,500 shares — an estimated $14.5M sold.

Stelliam Investment Management first reported a position in CC in Q1 2018 and held it in 1 quarter. The position peaked at $14.5M in Q1 2018. 558 funds tracked by Wall St. Rank hold CC as of Q2 2018.

  • Stelliam Investment Management reported no remaining Chemours position as of Q2 2018 after selling out during the quarter.
  • Stelliam Investment Management sold 297,500 Chemours shares in Q2 2018, an estimated $14.5M.
  • Stelliam Investment Management first reported a position in Chemours in Q1 2018 and held it in 1 quarter.
  • Stelliam Investment Management's Chemours position peaked at $14.5M in Q1 2018.
  • 558 funds tracked by Wall St. Rank held Chemours as of Q2 2018.

Based on Stelliam Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.